Financial Technology

Financial Technology - INDUSTRY NEWS


TMCNet:  AVANIR Pharmaceuticals Up 5.1%, Shares Break Through Resistance (AVNR)

[November 27, 2012]

AVANIR Pharmaceuticals Up 5.1%, Shares Break Through Resistance (AVNR)

Nov 27, 2012 (SmarTrend(R) Spotlight via COMTEX) -- AVANIR Pharmaceuticals (NASDAQ:AVNR) is one of today's best performing low-priced stocks, up 5.1% to $2.68 on 1.1x average daily volume. Thus far today, AVANIR Pharmaceuticals has traded 1.2 million shares, vs. average volume of 1.0 million shares per day. The stock has outperformed the Dow (5.1% to the Dow's -0.3%) and outperformed the S&P 500 (5.1% to the S&P's -0.3%) during today's trading.
Story continues below ↓

AVANIR Pharmaceuticals Inc. develops, acquires, and markets treatments for central nervous system disorders, inflammation, and infectious diseases.

There is potential upside of 217.2% for shares of AVANIR Pharmaceuticals based on a current price of $2.68 and an average consensus analyst price target of $8.50. The stock should find initial resistance at its 200-day moving average (MA) of $3.11 and further resistance at its 50-day MA of $3.22.

In the past 52 weeks, shares of AVANIR Pharmaceuticals have traded between a low of $1.77 and a high of $4.05 and are now at $2.68, which is 51% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.3%.

SmarTrend recommended that its subscribers protect gains by selling shares of AVANIR Pharmaceuticals on October 31st, 2012 by issuing a Downtrend alert when the shares were trading at $2.92. Since that call, shares of AVANIR Pharmaceuticals have fallen 12.5%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Write to Chip Brian at --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

[ Back To Financial Technology's Homepage ]